| scholarly article | Q13442814 |
| P2093 | author name string | M O McClure | |
| P D Bieniasz | |||
| C L Hill | |||
| P2860 | cites work | Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line | Q29547239 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | gene therapy | Q213901 |
| vector-borne disease | Q2083837 | ||
| P304 | page(s) | 2003-9 | |
| P577 | publication date | 1999-08-01 | |
| P1433 | published in | Journal of General Virology | Q6295245 |
| P1476 | title | Properties of human foamy virus relevant to its development as a vector for gene therapy | |
| P478 | volume | 80 ( Pt 8) |
| Q39462032 | A new indicator cell line established to monitor bovine foamy virus infection |
| Q39369916 | A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectors |
| Q36014053 | Advances in foamy virus vector technology and disease correction could speed the path to clinical application |
| Q39775287 | Analysis of bovine foamy virus btas mRNA transcripts during persistent infection |
| Q39703179 | Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles |
| Q35104790 | Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats |
| Q39736138 | BFV activates the NF-kappaB pathway through its transactivator (BTas) to enhance viral transcription |
| Q34295911 | Bovine Foamy Virus Transactivator BTas Interacts with Cellular RelB To Enhance Viral Transcription |
| Q36954062 | Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors |
| Q45354422 | Characterization and manipulation of foamy virus membrane interactions |
| Q42218331 | Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain |
| Q36334380 | Cocirculation of Two env Molecular Variants, of Possible Recombinant Origin, in Gorilla and Chimpanzee Simian Foamy Virus Strains from Central Africa |
| Q40182244 | Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome |
| Q40630425 | Determinants of foamy virus envelope glycoprotein mediated resistance to superinfection |
| Q28650068 | Discovery of prosimian and afrotherian foamy viruses and potential cross species transmissions amidst stable and ancient mammalian co-evolution |
| Q38097291 | Early events in foamy virus-host interaction and intracellular trafficking |
| Q24792862 | Early steps of retrovirus replicative cycle |
| Q39603905 | Efficacy of dideoxynucleosides against human foamy virus and relationship to its reverse transcriptase amino acid sequence and structure |
| Q39948199 | Establishment of an indicator cell line to quantify bovine foamy virus infection |
| Q51238826 | Evaluation and prediction of the HIV-1 central polypurine tract influence on foamy viral vectors to transduce dividing and growth-arrested cells. |
| Q38121801 | Feline foamy virus-based vectors: advantages of an authentic animal model |
| Q26864134 | Foamy virus biology and its application for vector development |
| Q34704560 | Foamy virus for efficient gene transfer in regeneration studies |
| Q36548744 | Foamy virus infection in primates. |
| Q34334976 | Foamy virus vector integration sites in normal human cells |
| Q37594766 | Foamy virus vectors for gene transfer |
| Q92670196 | Frequent cross-species transmissions of foamy virus between domestic and wild felids |
| Q40746225 | Gene transfer with foamy virus vectors |
| Q24550692 | Historical perspective of foamy virus epidemiology and infection |
| Q36694049 | Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein. |
| Q40369503 | Inhibition of simian immunodeficiency virus by foamy virus vectors expressing siRNAs |
| Q91887801 | Inhibitors of the interferon response increase the replication of gorilla simian foamy viruses |
| Q39441971 | Innate sensing of foamy viruses by human hematopoietic cells |
| Q39590740 | Isolation and characterization of an equine foamy virus |
| Q45674657 | Kinetics and characteristics of replication-competent revertants derived from self-inactivating foamy virus vectors |
| Q36482767 | Large animal models for foamy virus vector gene therapy |
| Q34452109 | Lentivirus and foamy virus vectors: novel gene therapy tools |
| Q37743255 | Molecular biology of foamy viruses |
| Q33603453 | Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells |
| Q28673358 | Non-simian foamy viruses: molecular virology, tropism and prevalence and zoonotic/interspecies transmission |
| Q39627850 | Novel functions of prototype foamy virus Gag glycine- arginine-rich boxes in reverse transcription and particle morphogenesis. |
| Q30336260 | Potential of zoonotic transmission of non-primate foamy viruses to humans. |
| Q35120176 | Progress and problems with the use of viral vectors for gene therapy |
| Q26781432 | Progresses towards safe and efficient gene therapy vectors |
| Q37170654 | Rapid and Efficient Stable Gene Transfer to Mesenchymal Stromal Cells Using a Modified Foamy Virus Vector |
| Q28306982 | Recombinant human foamy virus, a novel vector for neurological disorders gene therapy, drives production of GAD in cultured astrocytes |
| Q24299944 | Restriction of foamy viruses by APOBEC cytidine deaminases |
| Q24815564 | Retroviral superinfection resistance |
| Q37104705 | Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet |
| Q40448653 | Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors. |
| Q40337891 | The fourth central polypurine tract guides the synthesis of prototype foamy virus plus-strand DNA. |
| Q45880398 | The usefulness of a perfect parasite |
| Q40109118 | Transduction of human embryonic stem cells by foamy virus vectors |
| Q39909504 | Transduction of human neural progenitor cells with foamy virus vectors for differentiation-dependent gene expression |
| Q40596831 | Transient foamy virus vector production by adenovirus vectors |
| Q33934207 | Why aren't foamy viruses pathogenic? |
Search more.